Acidified Chloroquine Treatment for the Removal of Class I HLA Antigens
Vox Sanguinis, ISSN: 1423-0410, Vol: 65, Issue: 2, Page: 146-150
1993
- 11Citations
- 5Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes11
- 11
- CrossRef8
- Captures5
- Readers5
Article Description
With the aim of reducing the damage to platelets while effectively removing class I HLA antigens from their surfaces, we developed a new method using acidified chloroquine diphosphate. Platelets were treated with a 0.2 M solution of chloroquine diphosphate (pH 4.0). More than 90% of the platelets remained viable after treatment. While a marked reduction in reactions of acidified chloroquine‐treated platelets with multispecific HLA antisera was noted in comparison with phosphate‐buffered‐saline‐(PBS)‐treated platelets, reactions with platelet‐specific antibodies were preserved. This was demonstrated by immunofluorescence tests and solid‐phase and monoclonal antibody immobilization of platelet antigen assays. Aggregation responses, though reduced in comparison with PBS‐treated platelets, were still preserved after acidified chloroquine treatment. Ultrastructural analysis did not show any significant difference from PBS‐treated platelets. We conclude that treatment of platelets with acidified chloroquine diphosphate is a simple and effective method for removing class I HLA antigens from their surfaces with minimal damage to their structure and function. © 1993 S. Karger AG, Basel
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0027305583&origin=inward; http://dx.doi.org/10.1111/j.1423-0410.1993.tb02132.x; http://www.ncbi.nlm.nih.gov/pubmed/7692675; https://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.1993.tb02132.x; https://dx.doi.org/10.1111/j.1423-0410.1993.tb02132.x; https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1423-0410.1993.tb02132.x
Wiley
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know